Alzheimer's disease biomarkers: their value in diagnosis and clinical trials
David H. Small
[Frontiers in Bioscience 7, d986-988, April 1, 2002]

p97 as a biomarker for alzheimer disease
Maki Ujiie, Dara L. Dickstein and Wilfred A. Jefferies
[Frontiers in Bioscience 7, e42-47, February 1, 2002]

The AD7C-NTP neuronal thread protein biomarker for detecting Alzheimer's disease
Suzanne M. de la Monte and Jack R. Wands
[Frontiers in Bioscience 7, d989-996, April 1, 2002]

Significance of intracellular Ab42 accumulation in alzheimer's disease
T. Tabira, D. H. Chui, and S. Kuroda
[Frontiers in Bioscience 7, a44-49, April 1, 2002]

Cerebrospinal fluid Ab40 and Ab42: natural course and clinical usefulness
Mikio Shoji
[Frontiers in Bioscience 7, d997-1006, April 1, 2002]

Oxidative processes in the brain and non-neuronal tissues as biomarkers of Alzheimer's disease
Gary E. Gibson and Hsueh-Meei Huang
[Frontiers in Bioscience 7, d1007-1015, April 1, 2002]

Transition metal chelator therapy - a potential treatment for Alzheimer's disease?
Anastazija Gnjec, Justin A Fonte, Craig Atwood, Ralph N. Martins
[Frontiers in Bioscience 7, d1016-1023, April 1, 2002]

Pharmacological concentrations of the HMG-COA reductase inhibitor lovastatin decrease the formation of the Alzheimer b-amyloid peptide in vitro and in patients
Joseph D. Buxbaum, Edward I. Cullen and Lawrence T. Friedhoff
[Frontiers in Bioscience 7, a50-59, April 1, 2002]

Prion peptide 106-126 as a model for prion replication and neurotoxicity
Neena Singh, Yaping Gu, Sharmila Bose, Sudheera Kalepu, Ravi Shankar Mishra, and Susamma Verghese
[Frontiers in Bioscience 7, a60-71, April 1, 2002]